Diabetes and cancer, common threads and missing links

被引:66
作者
Hua, Fang
Yu, Jiao-Jiao
Hu, Zhuo-Wei [1 ]
机构
[1] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Immunol & Canc Pharmacol Grp, Beijing 100050, Peoples R China
基金
中国国家自然科学基金;
关键词
Hyperinsulinemia; Insulin resistance; Inflammation; Obesity; ER-stress; Autophagy; GROWTH-FACTOR-I; INDEPENDENT RISK-FACTOR; INSULIN-RECEPTOR IR; BODY-MASS INDEX; PANCREATIC-CANCER; METABOLIC SYNDROME; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; ENDOMETRIAL CANCER; LIVER-CANCER;
D O I
10.1016/j.canlet.2016.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diabetes mellitus is a serious and growing health problem worldwide and is associated with severe acute and chronic complications. Accruing epidemiological and clinical evidence have suggested that an increased cancer incidence is associated with diabetes as well as certain diabetes risk factors and diabetes medications. Several pathophysiological mechanisms for this relationship have been postulated, including insulin resistance and hyperinsulinemia, enhanced inflammation, aberrant metabolic state, endoplasmic reticulum stress, and deregulation of autophagy. In addition to these potential mechanisms, a number of common risk factors, including obesity, may be behind the association between diabetes and cancer. Furthermore, different anti-diabetic medications may modify cancer risk and mortality in patients with diabetes. This Review discusses evidence to support the relationship between diabetes and cancer development as well as the underlying mechanisms. We also discuss the relationship of current diabetes treatments and cancer risk or prognosis. Understanding the mechanisms that connect type 2 diabetes or diabetes treatments to cancer are crucial for establishing the fundamental strategies concerning about primary prevention, early detection and effective therapy against these diseases. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:54 / 61
页数:8
相关论文
共 93 条
[1]   Adrenomedullin is Up-regulated in Patients With Pancreatic Cancer and Causes Insulin Resistance in β Cells and Mice [J].
Aggarwal, Gaurav ;
Ramachandran, Vijaya ;
Javeed, Naureen ;
Arumugam, Thiruvengadam ;
Dutta, Shamit ;
Klee, George G. ;
Klee, Eric W. ;
Smyrk, Thomas C. ;
Bamlet, William ;
Han, Jing Jing ;
Vittar, Natalia B. Rumie ;
De Andrade, Mariza ;
Mukhopadhyay, Debabrata ;
Petersen, Gloria M. ;
Fernandez-Zapico, Martin E. ;
Logsdon, Craig D. ;
Chari, Suresh T. .
GASTROENTEROLOGY, 2012, 143 (06) :1510-+
[2]   Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms [J].
Arcidiacono, Biagio ;
Iiritano, Stefania ;
Nocera, Aurora ;
Possidente, Katiuscia ;
Nevolo, Maria T. ;
Ventura, Valeria ;
Foti, Daniela ;
Chiefari, Eusebio ;
Brunetti, Antonio .
EXPERIMENTAL DIABETES RESEARCH, 2012,
[3]   Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies [J].
Bansal, D. ;
Bhansali, A. ;
Kapil, G. ;
Undela, K. ;
Tiwari, P. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (02) :151-158
[4]   Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells [J].
Bao, Bin ;
Wang, Zhiwei ;
Ali, Shadan ;
Ahmad, Aamir ;
Azmi, Asfar S. ;
Sarkar, Sanila H. ;
Banerjee, Sanjeev ;
Kong, Dejuan ;
Li, Yiwei ;
Thakur, Shivam ;
Sarkar, Fazlul H. .
CANCER PREVENTION RESEARCH, 2012, 5 (03) :355-364
[5]   Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies [J].
Batabyal, Pikli ;
Vander Hoorn, Stephen ;
Christophi, Christopher ;
Nikfarjam, Mehrdad .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (07) :2453-2462
[6]   Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1 [J].
Ben Sahra, Isaam ;
Regazzetti, Claire ;
Robert, Guillaume ;
Laurent, Kathiane ;
Le Marchand-Brustel, Yannick ;
Auberger, Patrick ;
Tanti, Jean-Francois ;
Giorgetti-Peraldi, Sophie ;
Bost, Frederic .
CANCER RESEARCH, 2011, 71 (13) :4366-4372
[7]   Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults [J].
Borena, Wegene ;
Strohmaier, Susanne ;
Lukanova, Annekatrin ;
Bjorge, Tone ;
Lindkvist, Bjorn ;
Hallmans, Goran ;
Edlinger, Michael ;
Stocks, Tanja ;
Nagel, Gabriele ;
Manjer, Jonas ;
Engeland, Anders ;
Selmer, Randi ;
Haggstrom, Christel ;
Tretli, Steinar ;
Concin, Hans ;
Jonsson, Hakan ;
Stattin, Par ;
Ulmer, Hanno .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (01) :193-200
[8]   Diabetes and breast cancer risk: a meta-analysis [J].
Boyle, P. ;
Boniol, M. ;
Koechlin, A. ;
Robertson, C. ;
Valentini, F. ;
Coppens, K. ;
Fairley, L-L ;
Boniol, M. ;
Zheng, T. ;
Zhang, Y. ;
Pasterk, M. ;
Smans, M. ;
Curado, M. P. ;
Mullie, P. ;
Gandini, S. ;
Bota, M. ;
Bolli, G. B. ;
Rosenstock, J. ;
Autier, P. .
BRITISH JOURNAL OF CANCER, 2012, 107 (09) :1608-1617
[9]   Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail [J].
Brasacchio, Daniella ;
Okabe, Jun ;
Tikellis, Christos ;
Balcerczyk, Aneta ;
George, Prince ;
Baker, Emma K. ;
Calkin, Anna C. ;
Brownlee, Michael ;
Cooper, Mark E. ;
El-Osta, Assam .
DIABETES, 2009, 58 (05) :1229-1236
[10]   Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case-control study [J].
Chang, Shen-Shong ;
Hu, Hsiao-Yun .
BMC CANCER, 2013, 13